✦ LIBER ✦

Phase I study of an oral formulation of irinotecan administered daily for 14

✍ Scribed by Nadja E. Schoemaker; I. E. L. M. Kuppens; Wim W. Ten Bokkel Huinink; Patricia Lefebvre; Jos H. Beijnen; Sylvie Assadourian; Ger-Jan Sanderink; Jan H. M. Schellens

Publisher: Springer
Year: 2004
Tongue: English
Weight: 227 KB
Volume: 55
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0874-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetic study of a

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5

✍ Henry C. Pitot; Alex A. Adjei; Joel M. Reid; Jeff A. Sloan; Pamela J. Atherton; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 296 KB

A phase I trial of perillyl alcohol admi

A phase I trial of perillyl alcohol administered four times daily for 14

✍ Howard H. Bailey; George Wilding; Kendra D. Tutsch; Rhoda Z. Arzoomanian; Dona A 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 260 KB

A phase I and pharmacokinetic study of s

A phase I and pharmacokinetic study of sunitinib administered daily for 2

✍ Carolyn D. Britten; Fairooz Kabbinavar; J. Randolph Hecht; Carlo L. Bello; Jim L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 370 KB

Phase I and pharmacokinetic study of S-1

Phase I and pharmacokinetic study of S-1 administered for 14

✍ Andrew X. Zhu; Jeffrey W. Clark; David P. Ryan; Jeffrey A. Meyerhardt; Peter C. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 409 KB

Phase I study of oral JM216 given twice

Phase I study of oral JM216 given twice daily

✍ P. Beale; F. Raynaud; J. Hanwell; C. Berry; S. Moore; D. Odell; I. Judson 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 303 KB

Phase I study of oral menogaril administ

Phase I study of oral menogaril administered on a once weekly schedule

✍ David J. Stewart; Shailendra Verma; Jean A. Maroun; Lucille Robillard; Robert H. 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 741 KB

Forty-seven patients with solid tumors were treated on a phase I study of menogaril administered by mouth once per week. Nausea and vomiting were excessive at weekly doses of 350 and 450 mg/m2/week but were tolerable and controlled reasonably well by antiemetics at lower doses. There appeared to be